HCA Healthcare, Inc. $HCA Shares Sold by Diversified Trust Co

Diversified Trust Co lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 51.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,480 shares of the company’s stock after selling 16,404 shares during the period. Diversified Trust Co’s holdings in HCA Healthcare were worth $6,598,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Park Place Capital Corp lifted its stake in HCA Healthcare by 2,336.0% in the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares during the last quarter. Swiss National Bank increased its position in HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares during the last quarter. Cherokee Insurance Co acquired a new stake in shares of HCA Healthcare in the second quarter worth about $3,869,000. Finally, Harrell Investment Partners LLC raised its stake in shares of HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after acquiring an additional 1,158 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $473.79 on Tuesday. The stock has a market cap of $108.12 billion, a P/E ratio of 18.31, a price-to-earnings-growth ratio of 1.41 and a beta of 1.36. The stock has a fifty day moving average price of $476.47 and a 200 day moving average price of $421.52. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period last year, the firm earned $4.90 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HCA shares. Mizuho increased their price target on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a report on Friday, December 19th. Truist Financial lifted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 22nd. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $479.00.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.